Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus

BACKGROUND: Dipeptidyl peptidase-4 inhibitors (DPP-4i) provide a unique antihyperglycemic effect by regulating incretin peptides in type 2 diabetes mellitus (T2DM) patients who are inadequately controlled with insulin therapy. The aim of this study was to investigate the impact of DPP-4i on leptin c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xin, Bai, Yu, Wang, Zhuo, Zheng, Xiaohong, Jin, Zening, Liu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390252/
https://www.ncbi.nlm.nih.gov/pubmed/34446063
http://dx.doi.org/10.1186/s13098-021-00703-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390252/
https://www.ncbi.nlm.nih.gov/pubmed/34446063
http://dx.doi.org/10.1186/s13098-021-00703-x

Ejemplares similares